Skip to main content
. 2013 Sep 27;29(3):131–137. doi: 10.5625/lar.2013.29.3.131

Figure 1.

Figure 1

Application of neural stem cells (NSCs) therapies. NSCs the self-renew and differentiate into major cell types of the brain exist, such as astrocytes, oligodendrocytes, and neurons, in the developing and adult central nervous system (CNS). There have been describing the effects of NSC transplantation for achieving functional recovery from CNS damage. Therefore, NSCs may be a suitable component for treating neurological diseases such as stroke, Parkinson's diseases (PD), brain tumors, primary and metastatic tumors. GFAP; glial fibrillary acidic protein, RC2: radial glial cell marker, 6-OHDA; 6-hydroxydopamine, MPTP; 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine.